Optimising long-acting Testosterone Replacement Therapy: Delivery clinical value without compromise (Clinical lunch chat on-demand)

SG8RKJ~A

This practical CME discussion explores how clinicians can optimise long-acting testosterone replacement therapy (TRT) in appropriately diagnosed men with hypogonadism.

Learning Outcomes

  • Diagnose male hypogonadism appropriately, combining compatible symptoms with confirmed biochemical testosterone deficiency
  • Select appropriate patients for TRT and recognise contraindications and situations requiring specialist assessment
  • Differentiate between testosterone formulations, including the clinical implications of short- versus long-acting treatment
  • Recognise and manage common treatment challenges, including erythrocytosis, inadequate response, fluctuating symptoms and fertility considerations
  • Individualise long-term TRT according to clinical response, safety, patient preference and treatment burden.
ATTENTIONKindly note that if you attended the live webinar, you have already received 1 CPD point and will not be permitted to receive additional points for the report. Should this occur, the HPCSA will only record 1 CPD point from the live webinar, invalidating any additional CPD points from the report.Please note deNovo Medica ensures uploading of your CPD points to the HPCSA: please don't upload these yourself.

To access this module, please register or login: